Hyderabad Telangana, India

Sairam V V M Kalapatapu


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sairam V V M Kalapatapu: Innovator in Malic Enzyme Inhibitors

Introduction: Sairam V V M Kalapatapu is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly focusing on the development of compounds that act as malic enzyme (ME) inhibitors. His work is particularly relevant in the therapeutic treatment of disorders mediated by ME, including types of cancer.

Latest Patents: Kalapatapu holds a patent for his invention related to malic enzyme inhibitors. The patent outlines novel compounds that serve as ME inhibitors, detailing processes for their preparation and the therapeutic applications of these compounds. They are especially beneficial for treating disorders such as pancreatic ductal adenocarcinoma (PDAC) in humans. The compounds described in the patent have a specific structure, including variations such as pharmaceutically acceptable salts, stereoisomers, or deuterated analogs.

Career Highlights: Sairam V V M Kalapatapu is affiliated with Sun Pharma Advanced Research Company Limited, where he applies his expertise in drug development and innovation. His work is instrumental in pushing forward the boundaries of therapeutic solutions aimed at complex diseases.

Collaborations: Throughout his career, Kalapatapu has collaborated with esteemed colleagues such as Gaurav Sanjivkumar Sheth and Sabbirhusen Yusufbhai Chimanwala. These partnerships have played a crucial role in enhancing the quality and scope of his research efforts.

Conclusion: Sairam V V M Kalapatapu stands out as an accomplished inventor in the pharmaceutical industry, with a focus on malic enzyme inhibitors. His innovative approaches and dedication to addressing critical health challenges exemplify the role of inventors in advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…